Suppr超能文献

对萘醌的评估确定了乙酰化异拉帕醇是一种有效的选择性抗疟原虫剂。

Evaluation of naphthoquinones identified the acetylated isolapachol as a potent and selective antiplasmodium agent.

作者信息

Moreira Diogo R M, de Sá Matheus S, Macedo Taís S, Menezes Maria N, Reys José Rui M, Santana Antônio E G, Silva Thaissa L, Maia Gabriela L A, Barbosa-Filho José M, Camara Celso A, da Silva Tania M S, da Silva Katia N, Guimaraes Elisalva T, dos Santos Ricardo R, Goulart Marília O F, Soares Milena B P

机构信息

Fundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz , Salvador, BA , Brazil .

出版信息

J Enzyme Inhib Med Chem. 2015;30(4):615-21. doi: 10.3109/14756366.2014.958083. Epub 2014 Nov 28.

Abstract

This study reports on the design, synthesis and antiparasitic activity of three new semi-synthetic naphthoquinones structurally related to the naturally-occurring lapachol and lapachone. Of the compounds tested, 3-(3-methylbut-1-en-1-yl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate (1) was the most active against Plasmodium falciparum among both natural and semi-synthetic naphthoquinones, showing potent and selective activity. Compound 1 was able to reduce the in vitro parasite burden, in vitro parasite cell cycle, as well as the blood parasitemia in Plasmodium berghei-infected mice. More importantly, infection reduction under compound 1-treatment was achieved without exhibiting mouse genotoxicity. Regarding the molecular mechanism of action, this compound inhibited the hemozoin crystal formation in P. falciparum treated cells, and this was further confirmed by observing that it inhibits the β-hematin polymerization process similarly to chloroquine. Interestingly, this compound did not affect either mitochondria structure or cause DNA fragmentation in parasite treated cells. In conclusion, we identified a semi-synthetic antimalarial naphthoquinone closely related to isolapachol, which had stronger antimalarial activity than lapachol.

摘要

本研究报告了三种新的半合成萘醌的设计、合成及抗寄生虫活性,这些萘醌在结构上与天然存在的拉帕醇和拉帕酮相关。在所测试的化合物中,3-(3-甲基丁-1-烯-1-基)-1,4-二氧代-1,4-二氢萘-2-基乙酸酯(1)在天然和半合成萘醌中对恶性疟原虫的活性最强,表现出强效且具有选择性的活性。化合物1能够降低体外寄生虫负荷、体外寄生虫细胞周期以及伯氏疟原虫感染小鼠的血中疟原虫血症。更重要的是,在化合物1治疗下实现了感染减少,且未表现出对小鼠的遗传毒性。关于作用的分子机制,该化合物抑制了恶性疟原虫处理细胞中的疟色素晶体形成,并且通过观察到它与氯喹类似地抑制β-血红素聚合过程进一步得到证实。有趣的是,该化合物既不影响寄生虫处理细胞中的线粒体结构,也不导致DNA片段化。总之,我们鉴定出一种与异拉帕醇密切相关的半合成抗疟萘醌,其抗疟活性比拉帕醇更强。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验